TheProfitWatch

MRSN - Mersana Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
27.45 -0.15 (-0.56%) 0.04 (0.13%) 0.04 (0.13%) -0.14 (-0.52%) --- -0.15 (-0.56%) --- ---

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.19
Diluted EPS:
-0.19
Basic P/E:
-143.6579
Diluted P/E:
-143.6579
RSI(14) 1m:
48.39
VWAP:
27.28
RVol:

Events

Period Kind Movement Occurred At

Related News